RESEARCH HIGHLIGHT 29 May 2026 Death and the need for liver transplant were delayed in people with cirrhosis who received macrophage therapy. Cirrhosis causes severe scarring of the liver (pictured, liver cells from a person with the disease). Credit: Microscape/SPL Infusions of immune cells called macrophages have been linked to a reduction in the risk of death and the need for a liver transplant in people with cirrhosis 1 . Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Rent or buy this article Prices vary by article type from $1.95 to $39.95 Prices may be subject to local taxes which are calculated during checkout Additional access options: Log in Learn about institutional subscriptions Read our FAQs Contact customer support doi: https://doi.org/10.1038/d41586-026-01670-x References…